Consortium
The project strength the collaboration in multi-disciplinary network of scientists and physicians in both academic and industrial research.
Partners & Expertise
Project coordinator:
Justyna Siwy, Mosaiques Diagnostics GmbH
Proteome analysis using CE-MS-technology, the core technology used in UriCoV. Coordinator provides state of the art peptidomics profiling and clinical proteomics expertise. Coordinator further brings the central biostatistical and machine learning knowledge and competence to the consortium.
Partner 1:
Ralph Wendt, Hospital St. Georg Hospital, Leipzig, Germany
Clinical expertise in infectious diseases, access to human urine samples, data collection, integration and data management.
Partner 2:
Björn Peters, Skaraborg Hospital, Skövde, Sweden
Clinical partner, will provide expertise especially in the context of PASC and questionnaires.
Partner 3:
Benjamin Chousterman, Assistance publique – Hôpitaux de Paris, France
Special expertise on needs of patients after critical illness. In addition, P3 together with his team brings in the consortium expertise in the health economics analysis. The AP-HP team includes two public health doctors (Prof. K. Chevreul, Dr. M. Michel) specialized in health economics and economic evaluation, who are also part of an Inserm research unit dedicated to clinical epidemiology and economic evaluation applied to vulnerable populations.
Partner 4:
Miroslaw Banasik, Wroclaw Medical University, Poland
Clinical expertise; P4 is responsible for data integration.
Partner 5:
Manfred Hecking, Medical University of Vienna, Austria
Clinical expertise; qualitative interview study aiming to assess potential gender disparity in men and women with PACS.
Partner 6:
Catherine Tourette-Turgis, The Patients’ University, Sorbonne, France
Expertise in the field of the practices of survivor research. P6 has experience of activism in health in the field of long Covid.
Disclaimer
The website has been created to provide an overview of the UriCoV project. The information is provided by the UriCoV Consortium. The content of the website is for general information purposes only. We take the necessary steps to keep the information correct and up-to-date.
Efforts are made to keep the website up and running smoothly. However, our team takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen
Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.